This Thursday, Oct. 20, join Xconomy at “Boston’s Life Science Disruptors” for an evening of candid and interactive chats about some of the most disruptive areas in the life sciences industry. Don’t wait to register—our Fall Special ends tomorrow and it’s your last chance to save some cash on a ticket.
As always, we’ve convened some of Boston’s top biotech founders, investors, and leaders. This year, we’re featuring:
— Scott Manalis, Professor of biological & mechanical engineering, MIT
— Geraldine Hamilton, President & Chief Scientific Officer, Emulate
— Don Ingber, Founding Director, the Wyss Institute; Scientific Founder, Emulate
— Vicki Sato, Professor of Management Practice at Harvard Business School
— Terry McGuire, Founding Partner, Polaris Partners
— Nessan Bermingham, President, CEO, & Founder, Intellia Therapeutics
— Jean-Francois Formela, Partner, Atlas Venture
We’ll be discussing the challenges and potential of gene editing, organs-on-chips, and precision medicine, and the efforts that are being made by local leaders to close the gender gap in life sciences. You can find the full agenda for the evening here.
This is an event you won’t want to miss, so grab your ticket today.